"In short, Biogen ain't what it used to be," he said. "But the stock has also gotten a heck of a lot cheaper." A longtime leader of the biotech cohort, …
CNBC · 11d
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Evotec and Celgene Corporation ("Celgene") have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.
Finanzen · 3h
Watch! After analyzing the biotech space, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer doesn't have a catalyst for Celgene or Gilead.
Stock futures are marginally higher this morning ... meetings from PYPL (after just announcing a $2.2b purchase of IZettle), chip darling MU, and CELG, which boasts one of the uglier charts in large-cap biotech land. There are also two huge conferences ...
First American Bank sold 26,135 shares as Celgene Corp (CELG)’s stock declined 19.30%. The First American Bank holds 24,533 shares with $2.56M value, down from 50,668 last quarter. Celgene Corp now has $56.92 billion valuation. The stock …
Bibey Post · 1d